Effects of three-month streptozotocin-induced diabetes in mice on blood platelet reactivity, COX-1 expression and adhesion potential

International Journal of Experimental Pathology
Tomasz PrzygodzkiCezary Watala

Abstract

Diabetes is associated with an increased risk of cardiovascular disease. This is partially attributed to an altered activation status of blood platelets in this disease. Previously, alterations have been shown in COX-1 and protease activated receptor (PAR)-3 receptor expression in platelets in two animal models of diabetes, there have not been studies which address expression of these proteins in mice with long-term streptozotocin (STZ)-induced diabetes. We have also addressed the effect of diabetes on platelet adhesion under flow conditions. With the use of flow cytometry, we have shown that certain markers of platelet basal activation, such as active form of αIIb β3 and of CD40L were increased in STZ-induced diabetic mice. Platelets from STZ-induced diabetic mice were also more reactive when stimulated with PAR-4 activating peptide as revealed by higher expression of active form of αIIb β3 , membrane-bound on vWillebrand Factor and binding of exogenous fluorescein isothyanate-labelled fibrinogen. Expression of COX-1 and production of thromboxane A2 in platelets of STZ-induced diabetic mice were higher than in control animals. We observed no effect of diabetes on ability of platelets to form stable adhesions with fibrinogen in...Continue Reading

References

Jun 1, 1979·European Journal of Clinical Investigation·V A ZibohW Lucky
Jun 21, 1990·The New England Journal of Medicine·G DavìC Patrono
Dec 11, 1999·Prostaglandins & Other Lipid Mediators·T HishinumaM Mizugaki
Apr 15, 2000·Nature·M Nakanishi-MatsuiS R Coughlin
Oct 9, 2002·The Journal of Experimental Medicine·Steffen MassbergMeinrad Gawaz
Jul 10, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Andreas SchäferKeith M Channon
Sep 14, 2006·Autonomic & Autacoid Pharmacology·H A PeredoE Filinger
Oct 6, 2010·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·José Luis FerreiroDominick J Angiolillo
Feb 16, 2011·British Journal of Clinical Pharmacology·Timothy D WarnerCarl Whatling
May 17, 2012·PloS One·Abdul Q SheikhDaria A Narmoneva
Mar 28, 2013·International Journal of Hypertension·Alessandra Saldanha de Mattos MatheusMarilia de Brito Gomes
Nov 13, 2015·Expert Review of Cardiovascular Therapy·Udaya S TantryPaul A Gurbel

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.